| 1 |
Montreal Cognitive Assessment
(2705 times)
|
Neurology
(745 times)
|
MMSE (671 times)
MCI (378 times)
PD (281 times)
|
2007 Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease.
|
| 2 |
Montreal Cognitive Scale
(8 times)
|
Neurology
(2 times)
|
AD (2 times)
PSCI (2 times)
Abeta1-42 (1 time)
|
2018 [The relationship between the changes of serum NGF, HO-1, IL-1 beta and cognitive function in patients with severe OSAHS after comprehensive treatment].
|
| 3 |
Montreal Cognitive Function Assessment Scale
(3 times)
|
Biomedical Research
(1 time)
|
ACE-III (1 time)
AIS (1 time)
CAT (1 time)
|
2021 Physical, Cognitive and Social Rehabilitation in Relation to Sleep Quality and Cognitive Functions in the Elderly.
|
| 4 |
modular control analysis
(2 times)
|
Medicine
(1 time)
|
CH (1 time)
PCr (1 time)
PDE3 (1 time)
|
2010 Improved energy supply regulation in chronic hypoxic mouse counteracts hypoxia-induced altered cardiac energetics.
|
| 5 |
Montreal Cognitive Assessment Beijing Version
(2 times)
|
Neurology
(1 time)
|
ACE-III (1 time)
DS (1 time)
HRSD (1 time)
|
2014 Parkinson's disease patients with pain suffer from more severe non-motor symptoms.
|
| 6 |
Montreal Cognitive Evaluation Scale
(2 times)
|
General Surgery
(1 time)
|
6MWT (1 time)
ADL (1 time)
CAT (1 time)
|
2018 [Prevention of cognitive dysfunction in elderly cancer patients operated on the pelvic organs in conditions of multimodal anesthesia].
|
| 7 |
Montreal cognitive function scale
(2 times)
|
Internal Medicine
(1 time)
|
MMSE (2 times)
CBF (1 time)
CHP (1 time)
|
2011 [The evolution of cognition and its influence factors after stroke].
|
| 8 |
Montreal Cognitive test
(2 times)
|
Neoplasms
(1 time)
|
CHT (1 time)
MiCD (1 time)
MMSE (1 time)
|
2017 [Cognitive Deficits in Cancer Patients with Haematological Malignancies].
|
| 9 |
Montreal Overall Cognitive Assessment
(2 times)
|
Geriatrics
(1 time)
|
CCT (1 time)
MMSE (1 time)
PCT (1 time)
|
2020 A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool.
|
| 10 |
morphometric cytotoxicity assay
(2 times)
|
Clinical Laboratory Techniques
(2 times)
|
NK (1 time)
|
2002 Morphometric analysis of cytolysis in cultured cell monolayers: a simple and versatile method for the evaluation of the cytotoxic activity and the fate of LAK cells.
|
| 11 |
mainly in phonemic verbal fluency
(1 time)
|
Neurology
(1 time)
|
CDT (1 time)
MMSE (1 time)
|
2021 Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series.
|
| 12 |
MCI aggravating, while attention
(1 time)
|
Neurology
(1 time)
|
MCI (1 time)
|
2020 Investigation of risk factors for the conversion of mild cognitive impairment to dementia.
|
| 13 |
measures for cognitive status
(1 time)
|
Rehabilitation
(1 time)
|
QoL (1 time)
RNL (1 time)
RTW (1 time)
|
2015 What are the correlates of cognition and participation to return to work after first ever mild stroke?
|
| 14 |
medium/large effect size improvement in primary
(1 time)
|
Neurology
(1 time)
|
---
|
2019 A computer-based cognitive training in Mild Cognitive Impairment in Parkinson's Disease.
|
| 15 |
modified Rankin scale, cognitive functioning
(1 time)
|
Medicine
(1 time)
|
---
|
2020 The comprehensive evaluation of patients' condition in recovery and residual periods of aneurysmal subarachnoid hemorrhage.
|
| 16 |
Modular Control and Regulation Analysis
(1 time)
|
Biochemistry
(1 time)
|
---
|
2012 Non-invasive integrative analysis of contraction energetics in intact beating heart.
|
| 17 |
Montreal Assessment Cognitive
(1 time)
|
Psychiatry
(1 time)
|
---
|
2011 [The MoCA scale in diagnosis of the amnestic syndrome--case report].
|
| 18 |
Montreal Cognitive Assessment Questionnaire
(1 time)
|
Rheumatology
(1 time)
|
ACR (1 time)
ANAM (1 time)
CD (1 time)
|
2018 Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly.
|
| 19 |
Montreal Cognitive Assessment screening test
(1 time)
|
Dementia
(1 time)
|
GC (1 time)
MG (1 time)
PR (1 time)
|
2020 Cognitive performance in patients with Myasthenia Gravis: an association with glucocorticosteroid use and depression.
|
| 20 |
Montreal cognitive function assessment
(1 time)
|
Nervous System Diseases
(1 time)
|
AUC (1 time)
CMBs (1 time)
CSVD (1 time)
|
2022 Serum Cortisol Is Associated With Cerebral Small Vessel Disease-Related Brain Changes and Cognitive Impairment.
|
| 21 |
Montreal Cognitive Inventory
(1 time)
|
Complementary Therapies
(1 time)
|
CSVD (1 time)
MMSE (1 time)
MRA (1 time)
|
2019 [Effect of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease].
|
| 22 |
Montreal scale of cognitive dysfunction
(1 time)
|
General Surgery
(1 time)
|
FAB (1 time)
POCD (1 time)
VLCE (1 time)
|
2020 [Violations of higher mental functions and their correction in patients undergoing video laparoscopic cholecystectomy under conditions of inhalation anesthesia with sevoflurane].
|
| 23 |
Montreal Scale of Cognitive Function Assessment
(1 time)
|
Endocrinology
(1 time)
|
AD (1 time)
APOE (1 time)
CNS-VS (1 time)
|
2012 Polymorphisms of apolipoprotein E gene and cognitive functions of postmenopausal women, measured by battery of computer tests - Central Nervous System Vital Signs.
|
A Search Service for Abbreviation / Long Form